A LEADER IN REGENERATIVE MEDICINE

MimiClon, Inc. is a leading regenerative medicine company focused on the development, manufacturing and commercialization of unique proprietary extracellular matrix (ECM) products to facilitate the repair and remodeling of damaged tissues. All MimiClon products are based on our proprietary Urinary Bladder Matrix (UBM) technology platform.

MimiClon is committed to becoming and remaining an innovative leader in regenerative medical technology. MimiClon, which was established in 2002, is a privately held company and operates manufacturing facilities in Columbia, MD and Lafayette, IN.

MimiClon Vet is a subsidiary of MimiClon, Inc., and offers a complete line of regenerative medicine products for use in the veterinary field.